GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharos IBio Co Ltd (XKRX:388870) » Definitions » PB Ratio

Pharos IBio Co (XKRX:388870) PB Ratio : 6.44 (As of Jun. 03, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Pharos IBio Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-03), Pharos IBio Co's share price is ₩12720.00. Pharos IBio Co's Book Value per Share for the quarter that ended in Mar. 2024 was ₩1,975.78. Hence, Pharos IBio Co's PB Ratio of today is 6.44.

The historical rank and industry rank for Pharos IBio Co's PB Ratio or its related term are showing as below:

XKRX:388870' s PB Ratio Range Over the Past 10 Years
Min: 4.99   Med: 6.93   Max: 11.11
Current: 6.16

During the past 5 years, Pharos IBio Co's highest PB Ratio was 11.11. The lowest was 4.99. And the median was 6.93.

XKRX:388870's PB Ratio is ranked worse than
81.49% of 1313 companies
in the Biotechnology industry
Industry Median: 2.52 vs XKRX:388870: 6.16

During the past 12 months, Pharos IBio Co's average Book Value Per Share Growth Rate was 10.30% per year.

Back to Basics: PB Ratio


Pharos IBio Co PB Ratio Historical Data

The historical data trend for Pharos IBio Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharos IBio Co PB Ratio Chart

Pharos IBio Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
- - - - 6.76

Pharos IBio Co Quarterly Data
Mar22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial - - 5.95 6.76 9.48

Competitive Comparison of Pharos IBio Co's PB Ratio

For the Biotechnology subindustry, Pharos IBio Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharos IBio Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharos IBio Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharos IBio Co's PB Ratio falls into.



Pharos IBio Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Pharos IBio Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=12720.00/1975.777
=6.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Pharos IBio Co  (XKRX:388870) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Pharos IBio Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Pharos IBio Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharos IBio Co (XKRX:388870) Business Description

Traded in Other Exchanges
N/A
Address
427beon-gil, Dongan-gu, 1407 and 1408, 38, Heungan-daero, Seongji Star With, Gyeonggi-do, Gwanyang-dong, Anyang-si, KOR
Pharos IBio Co Ltd is a company specializing in new drug development that develops treatments for rare and intractable diseases. It utilizes a new drug development platform based on big data and AI technology. Its product candidate comprises PHI-101-AML, a treatment drug for refractory/relapsed acute myeloid leukemia; PHI-101-OC developed for platinum-resistant/refractory ovarian cancer patients; PHI-101-TNBC is being developed as a drug to treat metastatic triple-negative breast cancer (TNBC); PHI-201; PHI-301; and PHI-501.

Pharos IBio Co (XKRX:388870) Headlines

No Headlines